DOI 10.1016/j.jtct.2026.05.016
High Incidence of Cytomegalovirus Infection in Patients Receiving Standard of Care CD19- or BCMA-Targeted CAR-T Cell Therapies for Hematologic Malignancies.
Аннотация
BACKGROUND
Infections are a common source of nonrelapse morbidity and mortality (NRM) following chimeric antigen receptor (CAR)-T cell therapy. However, data regarding cytomegalovirus (CMV) are limited.
OBJECTIVE
We aimed to report the incidence and risk factors of CMV infection (CMVI) after CAR-T cell therapy and describe their clinical outcomes.
STUDY
DESIGN
We conducted a retrospective chart review study among patients who received commercial CAR-T therapy between May 21, 2021 and July 31, 2023 with undetectable CMV by quantitative polymerase chain reaction (PCR) prior to lymphodepletion (LD) and underwent at least 1 CMV PCR test post-CAR-T. The primary endpoint was the cumulative incidence of CMVI at day 30 post-CAR-T.
RESULTS
In total, 239 patients were included. After CAR-T, 50 patients (21%) had a positive CMV PCR at a median of 23 days (range: 3-602) postinfusion. The cumulative incidence of CMVI was 16% (95% CI = 12%-21%) at day 30, and 20% (95% confidence interval [CI] = 9%-18%) at day 100. By fitting a multivariable Cox proportional hazards model, patients with a positive CMV IgG at pre-LD or who received corticosteroid post CAR-T were at higher risk of developing a CMVI: adjusted hazard ratio (aHR) = 8.3, 95% CI = 2.6-26.9, P < .001; and aHR = 2.2, 95% CI = 1.2-4.2, P = .013, respectively.
CONCLUSION
CMVI is an underrecognized complication following CAR-T cell therapy. Patients with positive CMV IgG prior to LD, older age at LD, or who receive corticosteroids post-CAR-T are at higher risk for CMVI.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.